1. Home
  2. MNSB vs CCCC Comparison

MNSB vs CCCC Comparison

Compare MNSB & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MainStreet Bancshares Inc.

MNSB

MainStreet Bancshares Inc.

HOLD

Current Price

$22.61

Market Cap

148.8M

Sector

Finance

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$1.82

Market Cap

177.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNSB
CCCC
Founded
2003
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
148.8M
177.4M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MNSB
CCCC
Price
$22.61
$1.82
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.25
AVG Volume (30 Days)
65.6K
1.4M
Earning Date
01-26-2026
02-27-2026
Dividend Yield
1.80%
N/A
EPS Growth
N/A
N/A
EPS
1.76
N/A
Revenue
$73,642,000.00
$30,108,000.00
Revenue This Year
$0.46
N/A
Revenue Next Year
$4.14
N/A
P/E Ratio
$12.67
N/A
Revenue Growth
24.68
N/A
52 Week Low
$15.00
$1.09
52 Week High
$23.44
$3.65

Technical Indicators

Market Signals
Indicator
MNSB
CCCC
Relative Strength Index (RSI) 63.03 41.56
Support Level $22.07 $1.74
Resistance Level $22.86 $1.97
Average True Range (ATR) 0.56 0.13
MACD 0.01 -0.00
Stochastic Oscillator 68.98 28.87

Price Performance

Historical Comparison
MNSB
CCCC

About MNSB MainStreet Bancshares Inc.

MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: